Medications for the treatment of ACD have direct or indirect effects on iron homeostasis and include AHS, calcium channel blockers, cytokine antagonists, PHD inhibitors, kinase inhibitors, ESAs and multiple iron preparations (302, 407–411). The gene discussed is PDC; the disease is granular corneal dystrophy type II.